Latest News

LaRDR Annual Investigator Meeting – co-hosted with the Australasian Lymphoma Alliance (ALA)

26th November 2020

We provided progress updates on the work of both LaRDR and the ALA, as well as news on completed, ongoing, and planned projects. It was a great opportunity to meet and discuss and plan to collaborate for the future.
Program details:

  • Welcome/introduction
  • Overview of LaRDR and ALA
  • Project updates
  • Discussion

For further information about this event, see LaRDR and ALA scientific meeting 2020.

What is LaRDR?

The Lymphoma and Related Diseases Registry (LaRDR) is an Australasian initiative to improve the treatment and outcomes of patients with lymphoma.

The LaRDR is managed by Monash University’s School of Public Health and Preventive Medicine, through the Transfusion Research Unit, which manages a number of other clinical registries for important blood disorders.

The registry will include all new cases of Hodgkin and non-Hodgkin lymphomas at registered hospital sites.   National representative data on diagnosis and treatment will be collected, allowing the LaRDR team to

  • Understand access to care
  • Monitor trends in practice, outcomes and survival
  • Explore variation in factors that influence outcomes including survival and quality of life
  • Benchmark outcomes nationally and internationally
  • Act as a resource for clinical trials



Estimated number of new cases of Lymphoma diagnosed in Australia in 2019


Estimated number of deaths from Lymphoma in Australia in 2019


Chance of surviving Leukaemia in Australia for at least 5 years (2009-2013)

Source: Australian Institute of Health and Welfare. (2019). Cancer in Australia 2019. Canberra: AIHW.